After Dobbs Podcast Series
Since the Supreme Court's June 2022 decision in Dobbs v. Jackson Women's Health Organization, the U.S. health care system continues to adapt to the legal, regulatory, and policy challenges of this new and complex environment. In this podcast series, Delphine O'Rourke, Partner, Goodwin Procter LLP, brings together thought leaders from across the health law field to discuss the key issues that health law professionals must understand when advising their clients about this evolving legal landscape.
The Health Law Landscape
August 16, 2022
The health law landscape after Dobbs is complex at best. Melissa Scott, Managing Director, The Claro Group, LLC, speaks with Delphine O’Rourke, Partner, Goodwin Procter LLP, about the risks and unknowns for hospitals and employers as they re-examine how to deliver reproductive care and medicine to patients and employees. They discuss the expected and unexpected impacts on the health care industry, how health care providers and other stakeholders can manage risk, considerations surrounding contraceptives, and potential conflicts between EMTALA and state abortion laws. Sponsored by The Claro Group.
The Impact on Providers and Women’s Health
August 30, 2022
Providers and women face an uncertain landscape in the post-Dobbs health care system. Delphine O’Rourke, Partner, Goodwin Procter LLP, speaks with Dr. Somi Javaid, Founder, HERmd, about the impact of the Dobbs decision on providers and the future of women’s health. They discuss the unanticipated impacts on women’s access to care, what lawyers can do to help providers navigate the confusing legal environment, insurance coverage and supply chain concerns, and gender disparities in health care. Dr. Javaid is a leading women’s health expert and board-certified OB-GYN.
The Impact on Reproductive Medicine
November 4, 2022
The field of reproductive medicine is beginning to feel the effects of the post-Dobbs landscape. Delphine O’Rourke, Partner, Goodwin Procter LLP, speaks with Dr. Brian Levine, Founding Partner and Practice Director, CCRM New York, about how the field is reacting, particularly as it relates to innovation, surrogacy, and access to treatment. Dr. Levine is a leader in the field of reproductive medicine and the founder of Nodal, a surrogacy platform that is driving transparency between surrogates and intended parents.
The Impact on Telemedicine Abortion
November 18, 2022
The Dobbs decision has resulted in an increase in requests for telemedicine abortions. Delphine O’Rourke, Partner, Goodwin Procter LLP, speaks with Natalie Birnbaum, Legal and Legislative Policy Consultant, about the landscape of telemedicine abortion post-Dobbs, barriers to patient access, and how providers can navigate the risks. Natalie advises independent providers who are interested in offering telemedicine abortion services across state lines on their rights and risks. She recently authored an article on this topic for AHLA’s Health Law Weekly.
The Impact on Underserved Communities
December 6, 2022
The Dobbs decision has impacted communities that have historically been underserved by the U.S. health care system in particularly challenging ways. Delphine O’Rourke, Partner, Goodwin Procter LLP, speaks with Priya Bathija, Founder and CEO, Nyoo Health, about who these underserved communities are, how they are being impacted, and how legal counsel can advise clients who are working with these communities. Priya founded Nyoo Health to find new ways to deliver health care to women by providing strategic and advisory support, developing educational forums, and making critical investments in women.
Six Months Later
December 20, 2022
Six months after the Supreme Court released its decision on Dobbs, the health law landscape remains as complex as ever. In this follow up to their August 2022 podcast, Delphine O’Rourke, Partner, Goodwin Procter LLP, and Melissa Scott, Managing Director, The Claro Group, discuss how the health care system continues to evolve and some of the significant legal and policy issues at play. They discuss state legal and policy developments, enforcement activity, reproductive health, reproductive apps and privacy, innovations in contraception, and impacts on underserved communities and women’s health. Sponsored by The Claro Group - A Stout Business.